← Leaderboards
Emily S Jungheim
Northwestern University At Chicago
$913,836
Attributed
$913,836
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $266.8K · FY2020–23$500K$375K$250K$125K$0
'20
'21
'22
'23
Funding mix
By agency
NIH$913,836 · 1
By mechanism
R01$913,836 · 1
Top collaborators
No co-investigators on record.
Most similar at Northwestern University At Chicago
Same institution · by research overlap
- Emma Gargus$154,712
- Maxwell Ethan Edmonds$148,584
- Catherine A. Gao$418,384
Others in their field
Other Emerging Leaders on “Gonadotropin Hormone Releasing Hormone”
- Tanya Christineh Petrossian · Endomet Biosciences, Inc$5,932,914
- Michael Douglas Nelson · Ut Southwestern Medical Center$2,640,647
- Molly Bennette Moravek · University Of Michigan At Ann Arbor$2,587,605
- Emily G Jacobs · University Of California, San Diego$2,399,031
- Stephen Sunderland Palmer · Baylor College Of Medicine$1,720,319
- Diane Chen · Lurie Children'S Hospital Of Chicago$1,639,020
Research focus
Gonadotropin Hormone Releasing HormoneAgonistAlternative TherapiesFlareBioinformaticsBiological MarkersBiologyBirth RateAftercareFertilization In VitroClinical TrialsComplicationDetectionDiagnosisDouble-Blind Placebo Controlled TrialEmbryoEmbryo TransferEndometriosisEndometriosis-Related InfertilityEstrogensEtiologyAffectFertilizationGonadotropin-Releasing Hormone Receptor
Grant awards (4)
3/4: Pre-IVF treatment with a GnRH antagonist in women with endometriosis - A prospective double blind placebo controlled trial (PREGNANT)$138,871
R01 · FY2023 · HD · contact PI
3/4: Pre-IVF treatment with a GnRH antagonist in women with endometriosis - A prospective double blind placebo controlled trial (PREGNANT)$251,381
R01 · FY2022 · HD · contact PI
3/4: Pre-IVF treatment with a GnRH antagonist in women with endometriosis - A prospective double blind placebo controlled trial (PREGNANT)$256,801
R01 · FY2021 · HD · contact PI
3/4: Pre-IVF treatment with a GnRH antagonist in women with endometriosis - A prospective double blind placebo controlled trial (PREGNANT)$266,783
R01 · FY2020 · HD · contact PI